Publication | Closed Access
Fluorine‐18 labelling of oligonucleotides: Prosthetic labelling at the 5′‐end using the <i>N</i>‐(4‐[<sup>18</sup>F]fluorobenzyl)‐2‐bromoacetamide reagent
33
Citations
10
References
2003
Year
Prosthetic LabellingNucleic Acid ChemistryBioorganic ChemistryFluorine‐18 LabellingBiochemistryEngineeringNatural SciencesNucleic Acid BiomarkersNucleic Acid BiochemistryOligonucleotideMolecular BiologyBioconjugationChemical BiologyFluorine‐18‐labelled OligonucleotideSpecific RadioactivityMolecular ImagingBiomolecular Engineering
Abstract Labelled oligonucleotides are new imaging tools to study gene expression at the nucleic acid and protein levels. We have previously developed a universal method to label oligonucleotides at their 3′‐end with radiohalogens and particularly with fluorine‐18, the most widely used positron‐emitter, t 1/2 : 109.8 min. Using the same strategy, we herein report the fluorine‐18 labelling of oligonucleotides at their 5′‐end. A 18‐mer 2′O‐methyl modified oligoribonucleotide, bearing a phosphorothioate group at its 5′‐end, was conjugated to our fluorine‐18‐labelled reagent N ‐(4‐[ 18 F]fluorobenzyl)‐2‐bromoacetamide. The whole synthetic procedure yielded up to 1 GBq of fluorine‐18‐labelled oligonucleotide with a specific radioactivity of 37–74 GBq/μmol in 160 min. Copyright © 2003 John Wiley & Sons, Ltd.
| Year | Citations | |
|---|---|---|
Page 1
Page 1